Vident Investment Advisory, LLC Wave Life Sciences Ltd. Transaction History

Vident Investment Advisory, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$36.35 - $55.2 $469,423 - $712,852	-12,914 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$33.85 - $50.65 $92,884 - $138,983	2,744 Added 26.98%	12,914 $494,000
Q1 2018 May 14, 2018	BUY	$32.45 - $54.7 $330,016 - $556,299	10,170 New	10,170 $418,000

164

117M

148K

109K

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $1.24B
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Vident Investment Advisory, LLC with notifications on news.